IBM Retirement Fund’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-3,482
Closed -$366K 502
2022
Q1
$366K Sell
3,482
-150
-4% -$14.6K 0.05% 333
2021
Q4
$391K Sell
3,632
-2,549
-41% -$278K 0.05% 352
2021
Q3
$677K Hold
6,181
0.05% 326
2021
Q2
$579K Sell
6,181
-497
-7% -$45.7K 0.05% 373
2021
Q1
$615K Sell
6,678
-542
-8% -$45.7K 0.04% 375
2020
Q4
$528K Buy
7,220
+939
+15% +$69.8K 0.04% 432
2020
Q3
$488K Buy
6,281
+1,989
+46% +$137K 0.04% 370
2020
Q2
$239K Buy
+4,292
New +$184K 0.03% 472

Other funds holding HZNP

IBM Retirement Fund's HZNP Position: Q2 2022 in Review

IBM Retirement Fund sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2022, closing a stake of 3,482 shares — an estimated $366K sold.

IBM Retirement Fund first reported a position in HZNP in Q2 2020 and held it in 8 quarters. The position peaked at $677K in Q3 2021. 616 funds tracked by Wall St. Rank hold HZNP as of Q2 2022.

  • IBM Retirement Fund reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • IBM Retirement Fund sold 3,482 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2022, an estimated $366K.
  • IBM Retirement Fund first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2020 and held it in 8 quarters.
  • IBM Retirement Fund's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $677K in Q3 2021.
  • 616 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2022.

Based on IBM Retirement Fund's 13F filing for Q2 2022, filed 20 Jul 2022.